The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted healthcare providers and the public to the circulation of suspected counterfeit batches of Phesgo 600mg, a medicine used in the treatment of breast cancer. The agency disclosed this in a notice published on Tuesday on its website, following complaints received by the product’s Marketing Authorisation Holder, Roch...